Unilever signs with BioLeap

Consumer-goods group Unilever has signed a two-year agreement with US drug company BioLeap to develop consumer-goods products in the area of anti-aging using BioLeap technology. Unilever states that the research will span several product categories. Japanese group Kao Corp is...
Read the full article now!
Subscribe